Production and Purification of a Recombinant Staphylococcal Enterotoxin B Vaccine Candidate Expressed in Escherichia coli
- 1 March 2002
- journal article
- Published by Elsevier in Protein Expression and Purification
- Vol. 24 (2) , 302-312
- https://doi.org/10.1006/prep.2001.1556
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genesPublished by Elsevier ,2004
- Evolving superantigens ofStaphylococcus aureusFEMS Immunology & Medical Microbiology, 2000
- Cross‐Reactive Antibodies Prevent the Lethal Effects ofStaphylococcus aureusSuperantigensThe Journal of Infectious Diseases, 1999
- Development of engineered vaccines effective against structurally related bacterial superantigensVaccine, 1998
- Identification of antigenic sites on staphylococcal enterotoxin B and toxoidFEMS Immunology & Medical Microbiology, 1997
- Superantigen Vaccines: A Comparative Study of Genetically Attenuated Receptor-Binding Mutants of Staphylococcal Enterotoxin AThe Journal of Infectious Diseases, 1996
- Bacterial superantigens in human disease: structure, function and diversityTrends in Microbiology, 1995
- Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex moleculesNature Structural & Molecular Biology, 1995
- Crossflow filtration for the separation of inclusion bodies from soluble proteins in recombinant escherichia coli cell lysateJournal of Membrane Science, 1990
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970